Isoniazid liver safety study for TB or latent TB patients
Part of Digestive system, Infections clinical trials.
This study looks at how often the TB drug isoniazid causes liver problems and what factors might predict them. It could help doctors monitor your liver health more safely if you are being treated with isoniazid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have tuberculosis (TB) or a latent TB infection and are being treated with isoniazid.
- Your liver tests (ALT, AST, bilirubin) are normal before starting treatment.
- You do not have any liver disease or symptoms of liver problems before starting.
- You are not pregnant or breastfeeding.
- You agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
This study tests a new type of lab test to find TB bacteria more accurately. It is for people who are being checked for latent (hidden) TB infection, or who have just been diagnosed with active TB. The goal is to see if the new test can help doctors diagnose TB better and faster.
This study aims to help find and start TB prevention medicine for people who have been in close contact with someone sick with TB. The goal is to protect more people, especially children, from getting sick.
This trial tests two shorter treatments (1HP or 3HR) to prevent TB infection from becoming active disease. It is for adults who live with someone who has drug-sensitive TB and have a positive test for TB infection.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This trial is looking for adults who might have tuberculosis, a related infection called non-tubercular mycobacteriosis, or a hidden (latent) tuberculosis infection. You will provide a sample for testing, and the study will help doctors understand and manage these infections better.
Hear when a new Tuberculosis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.